These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 34530077

  • 1. Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique.
    Bahrainian S, Mirmoeini MS, Gilani Z, Gilani K.
    Eur J Pharm Sci; 2021 Dec 01; 167():106008. PubMed ID: 34530077
    [Abstract] [Full Text] [Related]

  • 2. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 01; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 3. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N, Ahn P, Park H, Bhujbal S, Zemlyanov D, Cavallaro A, Mangal S, Li J, Zhou QT.
    Mol Pharm; 2018 Sep 04; 15(9):4004-4020. PubMed ID: 30028947
    [Abstract] [Full Text] [Related]

  • 4. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM.
    Int J Nanomedicine; 2013 Sep 04; 8():275-93. PubMed ID: 23355776
    [Abstract] [Full Text] [Related]

  • 5. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
    Hassan A, Farkas D, Longest W, Hindle M.
    Int J Pharm; 2020 Dec 15; 591():120027. PubMed ID: 33130220
    [Abstract] [Full Text] [Related]

  • 6. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT.
    Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544
    [Abstract] [Full Text] [Related]

  • 7. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.
    Xu Y, Harinck L, Lokras AG, Gerde P, Selg E, Sjöberg CO, Franzyk H, Thakur A, Foged C.
    Int J Pharm; 2022 Jun 10; 621():121758. PubMed ID: 35483619
    [Abstract] [Full Text] [Related]

  • 8. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
    Marasini N, Sheikh Z, Wong CYJ, Hosseini M, Spicer PT, Young P, Xin Ong H, Traini D.
    Int J Pharm; 2022 Aug 25; 624():121989. PubMed ID: 35809834
    [Abstract] [Full Text] [Related]

  • 9. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB, Tucker IG, Das SC.
    Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294
    [Abstract] [Full Text] [Related]

  • 10. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
    Zhang Q, Li Y, Li L, Cheng Y, Yu F, Li R, Hou S.
    AAPS PharmSciTech; 2023 Mar 14; 24(3):78. PubMed ID: 36918500
    [Abstract] [Full Text] [Related]

  • 11. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ, Worth Longest P, Hindle M.
    Int J Pharm; 2013 Feb 25; 443(1-2):137-45. PubMed ID: 23313343
    [Abstract] [Full Text] [Related]

  • 12. Leucine as an excipient in spray dried powder for inhalation.
    Alhajj N, O'Reilly NJ, Cathcart H.
    Drug Discov Today; 2021 Oct 25; 26(10):2384-2396. PubMed ID: 33872799
    [Abstract] [Full Text] [Related]

  • 13. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
    Wang Z, Wang H, Vehring R.
    Int J Pharm; 2021 May 15; 601():120561. PubMed ID: 33811968
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T, Li J, Morton DA, Zhou QT, Larson I.
    J Pharm Sci; 2016 Mar 15; 105(3):1156-63. PubMed ID: 26886330
    [Abstract] [Full Text] [Related]

  • 15. Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients.
    Yang XB, Wang XB, Pan WS, Xi RG, Wang YN, Liu D, Shi Y, Jiang S.
    Chem Pharm Bull (Tokyo); 2011 Mar 15; 59(8):929-37. PubMed ID: 21804235
    [Abstract] [Full Text] [Related]

  • 16. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
    Kaewjan K, Srichana T.
    Pharm Dev Technol; 2016 Mar 15; 21(1):68-75. PubMed ID: 25331092
    [Abstract] [Full Text] [Related]

  • 17. Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
    Boc S, Momin MAM, Farkas DR, Longest W, Hindle M.
    AAPS PharmSciTech; 2021 Apr 15; 22(4):136. PubMed ID: 33860409
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology.
    Tse JY, Kadota K, Imakubo T, Uchiyama H, Tozuka Y.
    Eur J Pharm Sci; 2021 Jan 01; 156():105600. PubMed ID: 33075466
    [Abstract] [Full Text] [Related]

  • 19. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J, Kutter JP, Mu H, Moodley A, Yang M.
    Int J Pharm; 2020 Nov 30; 590():119877. PubMed ID: 32927003
    [Abstract] [Full Text] [Related]

  • 20. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation.
    Raj Adhikari B, Sinha S, Lyons N, Pletzer D, Lamont I, Gordon KC, Das SC.
    Eur J Pharm Biopharm; 2022 Nov 30; 180():260-268. PubMed ID: 36241076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.